| 中文名 | Benzothiazolium, 2-[[4-[4-[4-(dimethylamino)phenyl]-1,3-butadien-1-yl]-2H-1-benzopyran-2-ylidene]methyl]-3-ethyl-, perchlorate (1:1) |
| 英文名 | Benzothiazolium, 2-[[4-[4-[4-(dimethylamino)phenyl]-1,3-butadien-1-yl]-2H-1-benzopyran-2-ylidene]methyl]-3-ethyl-, perchlorate (1:1) |
| 别名 | |
| CAS | 106025-71-2 |
| EINECS | |
| 化学式 | C31H29ClN2O5S |
| 分子量 | 577.09 |
| inchi | |
| 包装信息 | 250 mg |
| 价格 | $1,099 |
| 产品描述 | Benzothiazolium, 2-[[4-[4-[4-(dimethylamino)phenyl]-1,3-butadien-1-yl]-2H-1-benzopyran-2-ylidene]methyl]-3-ethyl-, perchlorate (1:1) LDS 867 is a potent and selective protein kinase D (PKD) inhibitor used in the biomedical industry for research on cancer treatment. It effectively inhibits PKD and displays anticancer activity against a range of malignancies, including breast and pancreatic cancers. LDS 867 is a valuable tool in the study of PKD signaling pathways and potential therapeutic strategies for various diseases. |
| 产品链接 | http://www.bocsci.com/lds-867-cas-106025-71-2-item-285552.html |
| 更新日期 | 2025-04-30 11:27:47 |